Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli

Kidney International

Volumn 86, Issue 3, 2014, Pages 506-514

  Ilatovskaya, Daria V ^a,b   Palygin, Oleg ^a   Chubinskiy Nadezhdin, Vladislav ^b   Negulyaev, Yuri A ^b,c   Ma, Rong ^d   Birnbaumer, Lutz ^e   Staruschenko, Alexander ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

^c PETER THE GREAT ST PETERSBURG POLYTECHNIC UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

angiotensin; calcium; focal segmental glomerulosclerosis; ion channel; nephrotic syndrome; podocyte

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM ION; GADOLINIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; 1-(2-(3-(4-METHOXYPHENYL)PROPOXY)-4-METHOXYPHENYLETHYL)-1H-IMIDAZOLE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; IMIDAZOLE DERIVATIVE; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPC6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHANNEL GATING; CHO CELL LINE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HORMONAL REGULATION; HORMONE ACTION; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; MALE; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CRICETULUS; DRUG EFFECTS; GENETICS; METABOLISM;

ANGIOTENSIN II; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CHO CELLS; CRICETULUS; GADOLINIUM; IMIDAZOLES; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PODOCYTES; RECEPTOR, ANGIOTENSIN, TYPE 1; TRPC CATION CHANNELS; UP-REGULATION;

EID: 84907598289     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.71     Document Type: Article

References (40)

1. Machuca E, Benoit G, Antignac C. Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology. Hum Mol Genet 2009; 18: R185-R194.
2. Reiser J, Polu KR, Moller CC et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37: 739-744.
3. Winn MP, Conlon PJ, Lynn KL et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801-1804.
4. Kobori H, Nangaku M, Navar LG et al. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
5. Bahiense-Oliveira M, Mattar AL, Malheiros DM et al. Interstitial expression of angiotensin II and AT1 receptor are increased in patients with progressive glomerulopathies. J Renin Angiotensin Aldosterone Syst 2010; 11: 158-164.
6. Gloy J, Henger A, Fischer KG et al. Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat. J Clin Invest 1997; 99: 2772-2781.
7. Greka A, Mundel P. Cell biology and pathology of podocytes. Annu Rev Physiol 2012; 74: 299-323.
8. Henger A, Huber T, Fischer KG et al. Angiotensin II increases the cytosolic calcium activity in rat podocytes in culture. Kidney Int 1997; 52: 687-693.
9. Sharma R, Sharma M, Vamos S et al. Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells. J Lab Clin Med 2001; 138: 40-49.
10. Hoffmann S, Podlich D, Hahnel B et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15: 1475-1487.
11. Fukuda A, Fujimoto S, Iwatsubo S et al. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome. Nephrology 2010; 15: 321-326.
12. Suzuki K, Han GD, Miyauchi N et al. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol 2007; 170: 1841-1853.
13. Brenner BM, Cooper ME, de ZD et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
14. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011; 365: 2398-2411.
15. Eckel J, Lavin PJ, Finch EA et al. TRPC6 enhances angiotensin II-induced albuminuria. J Am Soc Nephrol 2011; 22: 526-535.
16. Zhang H, Ding J, Fan Q et al. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation. Exp Biol Med 2009; 234: 1029-1036.
17. Nijenhuis T, Sloan AJ, Hoenderop JG et al. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol 2011; 179: 1719-1732.
18. Anderson M, Roshanravan H, Khine J et al. Angiotensin II activation of canonical transient receptor potential-6 (TRPC6) channels in rat podocytes requires generation of reactive oxygen species. J Cell Physiol 2014; 229: 434-442.
19. Ilatovskaya D, Staruschenko A. Single-channel analysis of TRPC channels in the podocytes of freshly isolated glomeruli. Methods Mol Biol 2013; 998: 355-369.
20. Ilatovskaya DV, Levchenko V, Ryan RP et al. NSAIDs acutely inhibit TRPC channels in freshly isolated rat glomeruli. Biochem Biophys Res Commun 2011; 408: 242-247.
21. Ilatovskaya DV, Palygin O, Levchenko V et al. Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli. Am J Physiol Cell Physiol 2013; 305: C1050-C1059.
22. Dryer SE, Reiser J. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol 2010; 299: F689-F701.
23. Goel M, Sinkins WG, Zuo CD et al. Identification and localization of TRPC channels in the rat kidney. Am J Physiol Renal Physiol 2006; 290: F1241-F1252.
24. Heeringa SF, Moller CC, Du J et al. A novel TRPC6 mutation that causes childhood FSGS. PLoS ONE 2009; 4: e7771.
25. Bon RS, Beech DJ. In pursuit of small molecule chemistry for calcium-permeable non-selective TRPC channels - mirage or pot of gold? Br J Pharmacol 2013; 170: 459-474.
26. Jung S, Muhle A, Schaefer M et al. Lanthanides potentiate TRPC5 currents by an action at extracellular sites close to the pore mouth. J Biol Chem 2003; 278: 3562-3571.
27. Foster RR, Zadeh MA, Welsh GI et al. Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells. Cell Calcium 2009; 45: 384-390.
28. Greka A, Mundel P. Balancing calcium signals through TRPC5 and TRPC6 in podocytes. J Am Soc Nephrol 2011; 22: 1969-1980.
29. Schaldecker T, Kim S, Tarabanis C et al. Inhibition of the TRPC5 ion channel protects the kidney filter. J Clin Invest 2013; 123: 5298-5309.
30. Nitschke R, Henger A, Ricken S et al. Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus. Kidney Int 2000; 57: 41-49.
31. Kim EY, Anderson M, Wilson C et al. NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex. Am J Physiol Cell Physiol 2013; 305: C960-C971.
32. Hsu HH, Hoffmann S, Endlich N et al. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J Mol Med 2008; 86: 1379-1394.
33. Tian D, Jacobo SM, Billing D et al. Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci Signal 2010; 3: ra77.
34. Giardino L, Armelloni S, Corbelli A et al. Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol 2009; 20: 1929-1940.
35. Kim EY, Anderson M, Dryer SE. Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death. Mol Pharmacol 2012; 82: 728-737.
36. Anderson M, Suh JM, Kim EY et al. Functional NMDA receptors with atypical properties are expressed in podocytes. Am J Physiol Cell Physiol 2011; 300: C22-C32.
37. Dietrich A, Mederos YS, Gollasch M et al. Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol Cell Biol 2005; 25: 6980-6989.
38. Ding Y, Winters A, Ding M et al. Reactive oxygen species-mediated TRPC6 protein activation in vascular myocytes, a mechanism for vasoconstrictor- regulated vascular tone. J Biol Chem 2011; 286: 31799-31809.
39. Piwkowska A, Rogacka D, Kasztan M et al. Insulin increases glomerular filtration barrier permeability through dimerization of protein kinase G type Ialpha subunits. Biochim Biophys Acta 2013; 1832: 791-804.
40. Sours S, Du J, Chu S et al. Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesangial cells. Am J Physiol Renal Physiol 2006; 290: F1507-F1515.